{
  "pmcid": "4678179",
  "config": {
    "model": "gemini",
    "strategy": "zero-shot"
  },
  "usage": {
    "input": 7148,
    "output": 613
  },
  "raw_text": "```json\n{\n  \"extractions\": [\n    {\n      \"outcome\": \"progression-free-survival (PFS)\",\n      \"intervention\": \"vismodegib plus gemcitabine (GV)\",\n      \"comparator\": \"gemcitabine plus placebo (GP)\",\n      \"outcome_type\": \"continuous\",\n      \"intervention_events\": null,\n      \"intervention_group_size\": 53,\n      \"comparator_events\": null,\n      \"comparator_group_size\": 53,\n      \"intervention_mean\": 4.0,\n      \"intervention_standard_deviation\": null,\n      \"comparator_mean\": 2.5,\n      \"comparator_standard_deviation\": null\n    },\n    {\n      \"outcome\": \"Median overall survival (OS)\",\n      \"intervention\": \"vismodegib plus gemcitabine (GV)\",\n      \"comparator\": \"gemcitabine plus placebo (GP)\",\n      \"outcome_type\": \"continuous\",\n      \"intervention_events\": null,\n      \"intervention_group_size\": 53,\n      \"comparator_events\": null,\n      \"comparator_group_size\": 53,\n      \"intervention_mean\": 6.9,\n      \"intervention_standard_deviation\": null,\n      \"comparator_mean\": 6.1,\n      \"comparator_standard_deviation\": null\n    },\n    {\n      \"outcome\": \"Response rates\",\n      \"intervention\": \"vismodegib plus gemcitabine (GV)\",\n      \"comparator\": \"gemcitabine plus placebo (GP)\",\n      \"outcome_type\": \"continuous\",\n      \"intervention_events\": null,\n      \"intervention_group_size\": 53,\n      \"comparator_events\": null,\n      \"comparator_group_size\": 53,\n      \"intervention_mean\": 8.0,\n      \"intervention_standard_deviation\": null,\n      \"comparator_mean\": 13.0,\n      \"comparator_standard_deviation\": null\n    },\n    {\n      \"outcome\": \"rate of adverse events\",\n      \"intervention\": \"vismodegib plus gemcitabine (GV)\",\n      \"comparator\": \"gemcitabine plus placebo (GP)\",\n      \"outcome_type\": \"binary\",\n      \"intervention_events\": null,\n      \"intervention_group_size\": 53,\n      \"comparator_events\": null,\n      \"comparator_group_size\": 53,\n      \"intervention_mean\": null,\n      \"intervention_standard_deviation\": null,\n      \"comparator_mean\": null,\n      \"comparator_standard_deviation\": null\n    }\n  ]\n}\n```",
  "extraction": [
    {
      "outcome": "progression-free-survival (PFS)",
      "intervention": "vismodegib plus gemcitabine (GV)",
      "comparator": "gemcitabine plus placebo (GP)",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 53,
      "comparator_events": null,
      "comparator_group_size": 53,
      "intervention_mean": 4.0,
      "intervention_standard_deviation": null,
      "comparator_mean": 2.5,
      "comparator_standard_deviation": null,
      "pmcid": "4678179"
    },
    {
      "outcome": "Median overall survival (OS)",
      "intervention": "vismodegib plus gemcitabine (GV)",
      "comparator": "gemcitabine plus placebo (GP)",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 53,
      "comparator_events": null,
      "comparator_group_size": 53,
      "intervention_mean": 6.9,
      "intervention_standard_deviation": null,
      "comparator_mean": 6.1,
      "comparator_standard_deviation": null,
      "pmcid": "4678179"
    },
    {
      "outcome": "Response rates",
      "intervention": "vismodegib plus gemcitabine (GV)",
      "comparator": "gemcitabine plus placebo (GP)",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 53,
      "comparator_events": null,
      "comparator_group_size": 53,
      "intervention_mean": 8.0,
      "intervention_standard_deviation": null,
      "comparator_mean": 13.0,
      "comparator_standard_deviation": null,
      "pmcid": "4678179"
    },
    {
      "outcome": "rate of adverse events",
      "intervention": "vismodegib plus gemcitabine (GV)",
      "comparator": "gemcitabine plus placebo (GP)",
      "outcome_type": "binary",
      "intervention_events": null,
      "intervention_group_size": 53,
      "comparator_events": null,
      "comparator_group_size": 53,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "4678179"
    }
  ]
}